Biomarker-driven optimal designs for patient enrollment restriction
Statistical Methods in Medical Research · 2025-09 · 34 (9) · 1821-1837
DOI: 10.1177/09622802251327690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, online erschienen am 31.03.2025. Verfasst von Alessandro Baldi Antognini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Biomarkers, Precision Medicine, Patient Selection, Research Design. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, Optimal and adaptive designs for modern medical experimentation.
Abstract (Originalsprache)
The rapidly developing field of personalized medicine is giving the opportunity to treat patients with a specific regimen according to their individual demographic, biological, or genomic characteristics, known also as biomarkers. While binary biomarkers simplify subgroup selection, challenges arise in the presence of continuous ones, which are often categorized based on data-driven quantiles. In the context of binary response trials for treatment comparisons, this paper proposes a method for determining the optimal cutoff of a continuous predictive biomarker to discriminate between sensitive and insensitive patients, based on their relative risk. We derived the optimal design to estimate such a cutoff, which requires a set of equality constraints that involve the unknown model parameters and the patients’ biomarker values and are not directly attainable. To implement the optimal design, a novel covariate-adjusted response-adaptive randomization is introduced, aimed at sequentially minimizing the Euclidean distance between the current allocation and the optimum. An extensive simulation study shows the performance of the proposed approach in terms of estimation efficiency and variance of the estimated cutoff. Finally, we show the potential severe ethical impact of adopting the data-dependent median to identify the subpopulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Statistical Sciences, University of Bologna, Bologna, Italy.
ORCID-Profile: Alessandro Baldi Antognini, Sara Cecconi, Rosamarie Frieri, Maroussa Zagoraiou
Förderung
- NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
- Optimal and adaptive designs for modern medical experimentation
Zitieren
APA
Baldi Antognini, A., Cecconi, S., Frieri, R., & Zagoraiou, M. (2025). Biomarker-driven optimal designs for patient enrollment restriction. Statistical Methods in Medical Research, 34(9), 1821-1837. https://doi.org/10.1177/09622802251327690
Vancouver
Baldi Antognini A, Cecconi S, Frieri R, Zagoraiou M. Biomarker-driven optimal designs for patient enrollment restriction. Statistical Methods in Medical Research. 2025;34(9):1821-1837. doi:10.1177/09622802251327690
BibTeX
@article{BaldiAntognini2025,
author = {Baldi Antognini, Alessandro and Cecconi, Sara and Frieri, Rosamarie and Zagoraiou, Maroussa},
title = {Biomarker-driven optimal designs for patient enrollment restriction},
journal = {Statistical Methods in Medical Research},
year = {2025},
volume = {34},
number = {9},
pages = {1821--1837},
doi = {10.1177/09622802251327690}
}
EUVIMED